Q3 2024 biopharma quarterly updates (11/11 to 11/15)
Q3 2024 biopharma quarterly updates continue next week…
Many smid-cap biopharma stocks reporting next week, from 11/11 to 11/15!
» 31 micro-cap
» 21 small-cap
» 8 mid-caps
» 0 large caps
📌 Ticker / Market cap / commercial stage (Y/N)* / (AM/PM)**
11/11/24
$RMTI / $124.3M / Y / AM
$MLYS / $671.8M / N / PM
$ASRT / $97.2M / Y / PM
11/12/24
$LEGN / $8.2B / Y / AM
$AXSM / $4.3B / Y / AM
$SRRK / $2.6B / N / AM
$SWTX / $2.3B / Y / AM
$WVE / $2.0B / N / AM
$MIRM / $1.9B / Y / AM
$NMRA / $1.9B / N / AM
$NVAX / $1.5B / Y / AM
$AVDL / $1.4B / Y / AM
$SDGR / $1.3B / N / AM
$AUTL / $899.3M / N / AM
$ALT / $499.6M / N / AM
$HRTX / $268.4M / Y / AM
$CGEN / $146.8M / N / AM
$ABOS / $191.1M / N / AM
$OPTN / $115.1M / Y / AM
$SGMO / $449.7M / N / PM
$LXRX / $428.3M / Y / PM
$TBPH / $404.5M / Y / PM
$VYGR / $362.6M / N / PM
$LGVN / $32.3M / N / PM
$FGEN / $30.3M / Y / PM
$CRNX / $5.2B / N / PM
$BLTE / $2.1B / N / PM
$ATRA / $58.4M / N / PM
$CRVS / $563.5M / N / PM
$ETON / $223.9M / Y / PM
$EYEN / $42.7M / Y / PM
$LSTA / $24.0M / N / PM
$PRTA / $989.5M / N / PM
$XENE / $3.41B / N / PM
11/13/24
$PYPD / $65.2M / N / AM
$LQDA / $876.1M / N / AM
$ACXP / $30.1M / N / AM
$FULC / $216.5M / N / AM
$IPHA / $127.4M / Y / AM
$KMDA / $345.5M / N / AM
$MCRB / $124.2M / Y / AM
$MRSN / $306.6M / N / AM
$SPRY / $1.53B / Y / AM
$TLPH / $15.1M / Y / PM
$CAPR / $825.3M / N / PM
$DRRX / $43.4M / Y / PM
$SCPH / $215.6M / Y / PM
$SLRN / $594.8M / N / PM
$VXRT / $163.3M / N / PM
11/14/24
$IMAB / $91.4M / N / AM
$AFMD / $57.5M / N / AM
$DMAC / $180.4M / N / AM
$IVVD / $120.0M / N / AM
$OCUL / $1.6B / Y / AM
$PLX / $88.9M / Y / AM
$CRIS / $35.0M / Y / AM
$INO / $143.3M / N / PM
$PSTV / $7.38M / N / PM
$DARE / $34.7M / Y / PM
$LCTX / $170.9M / N / PM
^FN
*If N then clinical-stage company
**AM - before market opens and PM - after market closes
See the calendar 📆for all the biopharma tickers reporting next week.
👉 Check out our free quarterly readout calendar.
🛎️ Become a BPIQ Elite member & get...
All catalyst & PDUFA dates!
Big/Suspected Movers
Hedge fund analysis & M&A data!
Stock ideas from our model portfolio!
This article is not investment, tax, or legal advice. Please do your own diligence and seek advice from professional advisors representing your interests.
Article history:
First published 11/07/24 SK, JD, DG & EJV